Davide Facchinelli

Vicenza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy.

Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy.

Journal: British journal of haematology

Published: May 15, 2026

Real-Life Study on Gilteritinib-Related Infections (GilteRInf): An Italian SEIFEM Study.

Real-Life Study on Gilteritinib-Related Infections (GilteRInf): An Italian SEIFEM Study.

Journal: American journal of hematology

Published: May 07, 2026

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project.

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project.

Journal: Cancers

Published: April 08, 2026

Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.

Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.

Journal: Hematological oncology

Published: February 14, 2026

Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A SEIFEM Retrospective Review.

Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A SEIFEM Retrospective Review.

Journal: American journal of hematology

Published: February 09, 2026

Outcomes of patients with de novo and secondary acute myeloid leukaemia treated with front-line hypomethylating agents and venetoclax: A retrospective Italian study.

Outcomes of patients with de novo and secondary acute myeloid leukaemia treated with front-line hypomethylating agents and venetoclax: A retrospective Italian study.

Journal: British journal of haematology

Published: January 07, 2026

Passenger lymphocyte syndrome after living-donor kidney transplantation with minor ABO incompatibility: a case report.

Passenger lymphocyte syndrome after living-donor kidney transplantation with minor ABO incompatibility: a case report.

Journal: Blood transfusion = Trasfusione del sangue

Published: November 11, 2025

Improved Detection of Minimal Residual Disease in AML: Validation of IDH1/2 ddPCR Assays in the Perspective of Treatment with Target Inhibitors.

Improved Detection of Minimal Residual Disease in AML: Validation of IDH1/2 ddPCR Assays in the Perspective of Treatment with Target Inhibitors.

Journal: International journal of molecular sciences

Published: August 19, 2025

Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.

Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.

Journal: Annals of hematology

Published: August 27, 2024

Palliative care is related to less aggressive end-of-life treatment in haematology-oncology: a retrospective cohort study.

Palliative care is related to less aggressive end-of-life treatment in haematology-oncology: a retrospective cohort study.

Journal: BMJ supportive & palliative care

Published: July 18, 2024

A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.

A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.

Journal: Blood cancer journal

Published: December 08, 2023

Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.

Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.

Journal: American journal of hematology

Published: October 11, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026